Co-Authors
This is a "connection" page, showing publications co-authored by Yanqun Wang and Nanshan Zhong.
Connection Strength
1.095
-
Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients. Genome Med. 2021 02 22; 13(1):30.
Score: 0.233
-
Narrative review of the novel coronavirus SARS-CoV-2: update on genomic characteristics, transmissions and animal model. J Thorac Dis. 2020 Dec; 12(12):7454-7466.
Score: 0.229
-
Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020 10 01; 130(10):5235-5244.
Score: 0.226
-
Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo. Cell Discov. 2021 Aug 12; 7(1):65.
Score: 0.060
-
Longitudinal virological changes and underlying pathogenesis in hospitalized COVID-19 patients in Guangzhou, China. Sci China Life Sci. 2021 12; 64(12):2129-2143.
Score: 0.059
-
Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery. Signal Transduct Target Ther. 2021 04 15; 6(1):155.
Score: 0.059
-
Mapping and role of T cell response in SARS-CoV-2-infected mice. J Exp Med. 2021 04 05; 218(4).
Score: 0.059
-
Population Bottlenecks and Intra-host Evolution During Human-to-Human Transmission of SARS-CoV-2. Front Med (Lausanne). 2021; 8:585358.
Score: 0.058
-
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg Microbes Infect. 2020 Dec; 9(1):991-993.
Score: 0.057
-
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. 2020 08 06; 182(3):734-743.e5.
Score: 0.055